Novel nonapeptide GLP (28–36) amide derivatives with improved hypoglycemic and body weight lowering effects
-
Add time:08/02/2019 Source:sciencedirect.com
Glucagon-like peptide-1 (GLP-1) has emerged as a major therapeutic target for the treatment of type 2 diabetes. The nonapeptide GLP-1 (28–36) amide is one of the biological C-terminal products of GLP-1 modified by the neutral endopeptidase (NEP) 24.11 with limited hypoglycemic activity. In this study, we focused on the modification of GLP-1 (28–36) amide for the first time and synthesized a series of GLP-1 (28–36) amide analogues. Results of biological activity evaluation in INS-1 cell, STZ-induced diabetic and diet induced obesity (DIO) mice indicated that S3 as a promising candidate to treat type 2 diabetes and obesity.
We also recommend Trading Suppliers and Manufacturers of peptide T amide (cas 113021-67-3). Pls Click Website Link as below: cas 113021-67-3 suppliers
Prev:Synthesis of Leu-enkephalin peptidomimetics containing trifluoromethylalkenes as amide isopolar mimics
Next:Caffeic amide derivatives inhibit allergen-induced bone marrow-derived dendritic cell maturation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Gut satiety hormones cholecystokinin and glucagon-like Peptide-17-36 amide mediate anorexia induction by trichothecenes T-2 toxin, HT-2 toxin, diacetoxyscirpenol and neosolaniol08/04/2019
- Caffeic amide derivatives inhibit allergen-induced bone marrow-derived dendritic cell maturation08/03/2019
- Synthesis of Leu-enkephalin peptidomimetics containing trifluoromethylalkenes as amide isopolar mimics08/01/2019
- Electrostatic frequency maps for amide-I mode of β-peptide: Comparison of molecular mechanics force field and DFT calculations07/30/2019
- Peptide macrocyclization through amide-to-amide transpeptidation07/29/2019
- Potential roles for glucagon-like peptide-17–36 amide and cholecystokinin in anorectic response to the trichothecene mycotoxin T-2 toxin07/28/2019
- Mapping the amide-I vibrations of model dipeptides with secondary structure sensitivity and amino acid residue specificity, and its application to amyloid β-peptide in aqueous solution07/27/2019
